Authors
Latest:
Fixed-Ratio Combination of Basal Insulin and GLP-1 Receptor AgonistNinety percent of diabetes cases are type 2, which is a major cause of morbidity and mortality.
Latest:
Health Technology and the Rise of the E-PatientTechnology has become an essential part of health care.
Latest:
Boehringer Ingelheim Pharmaceuticals' PradaxaPradaxa (dabigatran etexilate) is the first oral direct thrombin inhibitor to be approved by the FDA.
Latest:
New Antimicrobials Expand Treatment OptionsEravacycline, Omadacycline, Plazomicin, and a Rifamycin Add to the Armamentarium for Treating Resistant Infections
Latest:
Taking Home Gold and the DC Public Health Case ChallengeEach year, the National Academy of Medicine hosts its DC Public Health Case Challenge to promote interdisciplinary, problem-based learning that focuses on an important public health issue facing the Washington, DC community
Latest:
Three Current Policy Discussions Influencing Cancer Drug DevelopmentDespite progress in reducing cancer mortality, more work is needed to improve patient outcomes in this disease state.
Latest:
Securing Specialty Oncology Contracts in a Data-Driven WorldData aggregation partners can provide value in their ability to pull clinical information from both the HSSP and electronic health records.
Latest:
Pharmacists Play a Critical Role in Treating Alzheimer DiseaseIdentifying drug-related problems is a vital component of medication therapy management.
Latest:
Hereditary Angioedema: The Pharmacist's Role in Team-Based Patient CareAs medication experts, pharmacists are integral to team-based care, providing the requisite knowledge for medication therapy management, as well as initiating, modifying and monitoring drug therapy to benefit patient care.
Latest:
Ubrelvy: Treatment for Acute Migraines With or Without Aura in AdultsUbrogepant (Ubrelvy, Allergan) was approved for the treatment of acute migraines with or without aura in adults after showing a significantly greater reduction in headache pain compared with placebo.
Latest:
Economic Model of Granulocyte Colony-Stimulating Factors for Patients Receiving ChemotherapyFor US payers, pegfilgrastim is a less-expensive choice than daily filgrastim for reducing the risk of febrile neutropenia in patients receiving myelosuppressive chemotherapy.
Latest:
Why I Became a Pharmacist: Searching for Cures, Making a DifferenceThe winner of our third annual essay contest shares her story.
Latest:
Encourage Patient Accountability for Optimal Medication SafetyPatient-centered care involves educating and empowering individuals to take responsibility for their own care.
Latest:
Manufacturer Considerations for Designing a Distribution Strategy for Specialty ProductsThe rising cost of specialty drugs continues to put pressure on all stakeholders. Specialty pharmacists can fill an existing gap in compliance and cost control.
Latest:
Cost-Utility Analysis of Treatments for Advanced Non-Small Cell Lung CancerA national community-level study of Medicare patients with advanced non-small cell lung cancer found that adding targeted therapy to chemotherapy regimens was not cost-effective.
Latest:
Artificial Intelligence Applications in Education and Pharmacy PracticeBy interpreting and applying the data provided by algorithms, pharmacists are uniquely equipped to guide development of more patient-centered care.
Latest:
Implications of STeP for Improved Diabetes Control: A Payer PerspectiveImplementation of the STeP program across managed care organizations could lead to improved patient outcomes and significant cost savings.
Latest:
US Primary Care Providers' Use of Over-the-Counter Medications for Gastroesophageal Reflux Disease and Chronic ConstipationThe perception and utilization of OTC medications among primary care providers for gastroesophageal reflux disease and chronic constipation shows a need for improved patient education on these medications.
Latest:
Student Pharmacist Leaders Discuss the Future of PharmacyStudent pharmacist leaders were also asked about the importance of a pharmacist education in obtaining advanced pharmacist roles in their careers.
Latest:
Ensuring Access to Vaccinations Among Older Adults and Underserved PopulationsA broader understanding of vaccine hesitancy and barriers has helped to enhance acceptance of vaccination services through educational outreach.
Latest:
Medicare Part D Plans Burdened by Hospice Payment ReformRecent guidance and proposed rules for the Medicare hospice program will have a profound impact on plans providing Medicare Part D services.
Latest:
Treatment of Acute Venous Thromboembolism in Obese PatientsIn the United States, as many as 900,000 individuals are affected by venous thromboembolism each year.
Latest:
Electronic Prior Authorization: The First Step in Patient AdherenceA streamlined prior authorization process can increase administrative efficiency and improve health information security.
Latest:
5-HT3 Receptor Antagonist Effects in Cancer Patients With Multiple Risk FactorsPalonosetron has been found to be effective in treating chemotherapy-induced nausea and vomiting, but no other studies that have compared it with the other 5-HT3 RAs are currently available.
